Mucosal immunization with a recombinant adenovirus vector induces local and systemic immunity and protection from herpes simplex virus
Gallichan, W.S.; Johnson, D.C.; Graham, F.L.; Rosenthal, K.L.
Advances in Experimental Medicine and Biology 371b: 1581-1585
1995
ISSN/ISBN: 0065-2598 PMID: 7502860 Document Number: 451589
Document emailed within 1 workday
Related Documents
Timme, T.L.; Hall, S.J.; Barrios, R.; Woo, S.L.; Aguilar-Cordova, E.; Thompson, T.C. 1998: Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice Cancer Gene Therapy 5(2): 74-82Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Liu, W.; Zhao, D.; Wang, Z.; Li, Y.; Wang, H.; Wang, H. 2016: Construction and Immunogenicity Analysis of Herpes Simplex Virus Type 2 Glycoprotein D Recombinant Adenovirus Vaccine Bing du Xue Bao 32(3): 267-272
Parr, M.B.; Kepple, L.; McDermott, M.R.; Drew, M.D.; Bozzola, J.J.; Parr, E.L. 1994: A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2 Laboratory Investigation; a Journal of Technical Methods and Pathology 70(3): 369-380
Wang, Z.-y.; Wang, Z.-y.; Wen, H.-L.; Tao, Z.-x. 2005: ELISA study on application of recombinant glycoprotein D of herpes simplex virus-1 in diagnosis of herpes simplex virus-1 infection with ELISA Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 19(2): 159-161
Biesiadecka, A. 2000: Immunogenic activity of temperature sensitive mutation of herpes simplex virus type-1 in mono- and polyvalent conditions with different attenuated strains of virus. I. Analysis of humoral immunity induced by mutant temperature sensitive herpes simplex virus type-1 in monovalent systems Medycyna Doswiadczalna i Mikrobiologia 52(1): 81-88
Bright, R.K.; Shearer, M.H.; Kennedy, R.C. 1994: Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity Journal of Immunology 153(5): 2064-2071
Wu, Z.; Wu, X.; Hou, Y. 2002: Generation of a series of recombinant herpes simplex viruses which can provide replicating and packaging functions for recombinant adeno-associated virus Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 16(1): 74-78
Zvonarev, A.I.; Klichko, V.I.; Shatalin, K.I.; Kuliakina, M.N.; Karaseva, E.V. 1994: The determination of the antigenic activity of recombinant virus-specific polypeptides from the herpes simplex virus types 1 and 2 and their use in immunoenzyme analysis Voprosy Virusologii 39(2): 59-62
Prober, C.G.; Sullender, W.M.; Yasukawa, L.L.; Au, D.S.; Yeager, A.S.; Arvin, A.M. 1987: Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections New England Journal of Medicine 316(5): 240-244
Staats, H.F.; Nichols, W.G.; Palker, T.J. 1996: Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A) Journal of Immunology 157(1): 462-472
Siders, W.M.; Halloran, P.J.; Fenton, R.G. 1998: Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirus Cancer Gene Therapy 5(5): 281-291
Baker, D.A.; Gonik, B.; Milch, P.O.; Berkowitz, A.; Lipson, S.; Verma, U. 1989: Clinical evaluation of a new herpes simplex virus ELISA: a rapid diagnostic test for herpes simplex virus Obstetrics and Gynecology 73(3 Part 1): 322-325
Porgador, A.; Staats, H.F.; Faiola, B.; Gilboa, E.; Palker, T.J. 1997: Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo Journal of Immunology 158(2): 834-841
Bujko, M.; Sulović, V.; Sbutega-Milosević, G.; Zivanović, V. 1989: Mode of delivery and level of passive immunity against herpes simplex virus Clinical and Experimental Obstetrics and Gynecology 16(1): 6-8
Posevaia, T.A.; Barinskiĭ, I.F.; Grigor'ev, V.V.; Shuvaeva, N.I. 1982: Humoral immunity to herpes simplex virus type 2 in cervical cancer Voprosy Virusologii 27(3): 328-330
Sanchez-Pescador, L.; Burke, R.L.; Ott, G.; Van Nest, G. 1988: The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine Journal of Immunology 141(5): 1720-1727
Rudinger, R. 1993: Neues und Altes zu anogenitalen Herpes-simplex-Virus-Infektionen - New and old aspects of anogenital herpes simplex virus infections - New and old aspects of anogenital Herpes simplex virus infections University of Koln. Department of Dermatology. Dermatological Meeting 68(1): 20-23
Hayward, A.R.; Herberger, M.J.; Groothuis, J.; Levin, M.R. 1984: Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus Journal of Immunology 133(5): 2469-2473